Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer

prnasiaJanuary 21, 2022

Tag: Senhwa , Silmitasertib , Biliary Tract Cancer

PharmaSources Customer Service